Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.
about
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiaeFuture alternative therapies for β-thalassemia.Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutationsSynthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftorProtein quality control during erythropoiesis and hemoglobin synthesisGene therapy in thalassemia and hemoglobinopathies.Alternative options for DNA-based experimental therapy of β-thalassemia.Recent advances in gene therapy for thalassemia.Recent patents and technology transfer for molecular diagnosis of β-thalassemia and other hemoglobinopathies.Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cellsRescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides.Upf1 senses 3'UTR length to potentiate mRNA decay.Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation.Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.
P2860
Q28551611-053BE7A7-F6BE-4006-965E-9FE4B08B661FQ33659678-A13B1E43-298B-4BCD-9494-48C119B0976AQ33693359-FBDDB228-80A4-451D-82BB-A2B68582FF2AQ33799590-388F7021-29AE-4861-A364-7AF2DAA1456AQ34060218-B007A389-B878-4B5C-A8D2-4CF57E4A720FQ37854468-DB77E11D-C77F-4D94-8489-4773A3555B63Q37993118-B2FE5A7B-9DD4-485C-9D22-E750B01A339FQ38038167-573C8E88-62CA-4538-A13D-97AEAD4F3D7EQ38594354-0CB43348-F9DD-424B-B266-EFD58AA73D5EQ38939602-B8F6AEE6-93D1-410C-8603-65E87FBC0FA8Q39621228-C16270C0-404D-440B-A017-A9DB82C0BF13Q39638722-E2E9114B-A617-4A88-B1F1-9CCB3E3B04A3Q40746113-FD2FB765-0719-479E-A2A9-E62711B1D8E0Q42224585-39B12B75-C1BF-482F-A1E9-4E0B7E3DD971Q55005011-14DBD5F4-62CA-4863-9508-2F4C10DC7693Q55497000-11EC9317-77E6-4844-B966-67BE897C9BF2
P2860
Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@ast
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@en
type
label
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@ast
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@en
prefLabel
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@ast
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@en
P2093
P2860
P50
P356
P1476
Production of beta-globin and ...... eta(0)39 thalassemia patients.
@en
P2093
Alessandro Canella
Giordana Feriotto
Giulia Breveglieri
P2860
P304
P356
10.1002/AJH.21539
P50
P577
2009-11-01T00:00:00Z